MenuMENU
Meetings & Events > Conferences & Courses > Seminars in Forensic Toxicology > 2013 Forensic Course > Faculty
 

Faculty

Avery Dr. A. Nelson Avery is the Associate Dean for Development, Office of Institutional Advancement, Director of General Preventive Medicine Residency Program, and Professor of Instructional Administration at the Texas A&M Health Science Center College of Medicine (Round Rock campus). He graduated from the University of Texas Medical Branch (UTMB) in 1973, and was selected as a Distinguished Alumnus. Dr. Avery is triple boarded in Medical Toxicology, Preventive Medicine (in Occupational Medicine), and Internal Medicine. He has held private practice in Austin for 20 years, 13 years at UTMB as professor and director of the Occupational Medicine and General Preventive Medicine Residency Programs, and the past 3 years at A&M. He has done extensive expert witnessing in toxic tort cases nationally. Since 1992, Dr. Avery has been Senior Occupational Medicine Consultant to Motorola for its Semiconductor Products Sector (now called Freescale), developing international health standards and operating procedures. Since 1993, Dr. Avery has been a Senior Medical Consultant to Texas Mutual Insurance Company focusing on development of peer review network across state, pre-authorization protocols, treatment guidelines, fraud evaluation, medical case management, and evaluation of toxicology cases. Dr. Avery is a former elected member of the Medical Toxicology Subboard, Board of Directors of the American College of Occupational and Environmental Medicine, and Board of Directors of the Semiconductor Environmental Safety and Health Association. 
BrentJ Dr. Jeffrey Brent is a Distinguished Clinical Professor of Medicine and Pediatrics at the University of Colorado, School of Medicine, and Clinical Professor of Environmental and Occupational Medicine at the School of Public Health. He is the recipient of numerous honors and awards. Dr. Brent is the senior editor of Critical Care Toxicology: The Diagnosis and Treatment of the Acutely Poisoned Patient, is former Editor of Toxicological Reviews, and a member of the Editorial Board of Clinical Toxicology. He is a former President of the AACT and a former Board member of the ACMT. Dr. Brent’s areas of research are multi-center collaborations - specifically the development and application of the ToxIC network and Registry, methods used to diagnose mercury toxicity in autistic children by alternative medicine practitioners, the limitations of hair testing and provoked urine specimens in the evaluation of toxic exposures and injury, and the epidemiology of poisonings in infants, pregnancy and the elderly. In addition to his M.D., Dr. Brent holds a Ph.D. in biochemistry.
Burton
 
 
Dr. Brent T. Burton is a private practice Consulting Medical Toxicologist with board certification in Medical Toxicology, Occupational Medicine and Emergency Medicine. He has provided forensic toxicology consulting services for more than 30 years and has conducted more than 3000 toxicology IME’s. Dr. Burton graduated from the University of Utah with a BA in psychology in 1974 and MD in 1978. He completed emergency medicine training at Oregon Health and Sciences University (OHSU) and joined the faculty in 1981. He later took a sabbatical to attend the University of Washington and was awarded a Masters in Public Health. During his career at OHSU, Dr. Burton was the Medical Director for the Oregon Poison Center and founded a Medical Toxicology Fellowship Training Program. He also chaired the Pharmacy & Therapeutics Committee and was the Medical Director of the Occupational Health Program. He has also held elected positions in the AAPCC and the NW Chapter of ACOEM. Dr. Burton has volunteered his expertise in toxicology by serving on several hospital and public committees for issues that include water quality, drugs and alcohol, poison prevention, meth labs, and environmental cleanup standards.
Forney

Dr. Robert B. Forney, Jr. isChief Forensic Toxicologist, Lucas County Coroner's Office and Clinical Associate Professor, University of Toledo Health Science Center, Dept. of Pathology. Past Chair and member of the Executive Board, Alc. and Drug Impairment Division (formerly Comm on Alc. and Other Drugs, Highway Traffic Safety Div.) of the National Safety Council. Long standing faculty member of The Robert F. Borkenstein Course on Alcohol and Highway Safety: Testing, Research and Litigation, Dept. of Criminal Justice, Indiana University, Bloomington. Recipient of the Kurt M. Dubowski Lifetime Achievement Award of IACT and the Robert F. Borkenstein Award of the National Safety Council. Honorary Life Member, Phi Kappa Phi Honor Society, member of the Society of Forensic Toxicologists and Fellow, American Academy of Forensic Sciences.

 

Gill_Jim

Dr. James R. Gill is the Chief Medical Examiner for Connecticut. He is a graduate of M.I.T. and the University of Connecticut School of Medicine. He did his pathology training at Yale and Memorial Sloan-Kettering Cancer Center and is board certified in anatomic and forensic pathology. Prior to Connecticut, he was the deputy chief medical examiner for Bronx County in New York City.

Hail_Brian

Mr. Brian N. Hail is a founding member of Gruber Hurst Johansen Hail Shank, LLP-a Dallas, Texas litigation boutique firm.  His Firm has been named among the “Top Rated Law Firms in Texas” by LexisNexis Martindale-Hubbell and among “The Best Law Firms in the Country” by U.S. News and World Report.  He personally has been named as a “Texas Super Lawyer” by Texas Monthly Magazine every year since 2003 and one of the “Top Attorneys under 40” twice by D Magazine.  He has been Board Certified in Civil Trial Law by the Texas Board of Legal Specialization since 2003.  His practice involves commercial and employment litigation, representing both plaintiffs and defendants.  On the plaintiff’s side of the docket, he has 25 multi-million dollar judgments, verdicts, or settlements-including a $123 million judgment against Blockbuster Entertainment Corporation (the largest judgment against a single defendant in Dallas County history), a $38 million judgment against Associated Air Center (the largest judgment in Dallas County in 2013 and reason for his selection as “Litigator of the Week” by Texas Lawyer newspaper), a $30 million verdict against Shell Oil Company, and a $20 verdict against Roche Pharmaceutical (believed to be the largest sexual harassment verdict in U.S. history). 

Mr. Hail lectures frequently to the Bar and clients regarding various aspects of the practice of law, including cross examination, challenging experts, planning a civil case, and professionalism.

Hail_Stacey

Dr. Stacey L. Hail is an Assistant Professor of Surgery in the Division of Emergency Medicine at the University of Texas Southwestern Medical Center in Dallas, Texas. She obtained a Bachelor of Science in Chemistry from Southern Methodist University in 1995 and her Doctor of Medicine from the Medical College of Georgia in 1999. She completed her Residency in Emergency Medicine in 2002 and Fellowship in Medical Toxicology in 2004 from the University of Texas Southwestern Medical Center. She is currently Board Certified in both Emergency Medicine and Medical Toxicology. She actively works as an emergency physician in the Parkland Hospital emergency department and serves as a medical toxicologist in the North Texas Poison Center. She currently has a very busy forensic medical toxicology practice serving as an expert witness in Civil and Criminal cases and has provided live testimony in over a dozen trials.

Holland125w Dr. Michael G. Holland is a Consulting Medical Toxicologist at the Upstate NY Poison Center & Associate Professor at SUNY Upstate Medical University. He is Director of Occupational Medicine at Glens Falls Hospital Center for Occupational Health, where he has directed the drug and alcohol testing program for over twenty years. He serves on the Board of Directors of ACOEM, and Chair of the ACOEM Toxicology Committee and Co-Chair of the ACOEM Council of Scientific Advisors. He is also on the Board of Directors of the Medical Review Officer Certification Council (MROCC), and served on the Schedule II Medications Expert Panel for the DOT FMCSA in 2006. He serves on the Editorial Board of Clinical Toxicology, and is a peer-reviewer for the Journal of Medical Toxicology. He is board-certified in Medical Toxicology, Occupational Medicine, Emergency Medicine, and Undersea and Hyperbaric Medicine. His special research interests include forensic toxicology and post-mortem redistribution.
Kleinschmidt

Dr. Kurt C. Kleinschmidt is a Professor of Surgery in the Division of Emergency Medicine at the University of Texas Southwestern Medical Center in Dallas, Texas. He is the Section Chief and Program Director for Medical Toxicology. His areas of interest include venous and arterial thrombotic diseases, toxicology, and graduate medical education issues. He graduated from the University of South Florida College of Medicine in 1986, completed his Emergency Medicine residency at Madigan Army Medical Center in 1990, and finished a clinical fellowship in Toxicology at the University of Texas Southwestern Medical Center in 1999. He is board certified in both Emergency Medicine and Toxicology.

Logan

Dr. Barry K. Logan is a graduate of the University of Glasgow in Scotland graduating with degrees in chemistry and forensic toxicology in 1982 and 1986 respectively. He received four years postdoctoral training in forensic toxicology at the University of Tennessee Center for Health Sciences in Memphis. In 1990, he was appointed State Toxicologist and Assistant Professor of laboratory medicine at the University of Washington in Seattle, and in 1999 he was appointed Director of the Forensic Laboratory Services Bureau for the Washington State Patrol. He served in both positions until 2008, when he joined NMS Labs in Willow Grove, Pennsylvania, as National Director of Forensic and Toxicological Services. NMS Labs is an independent forensic laboratory, specializing in new drug detection and forensic analysis for the prosecution and defense in criminal justice and death investigation agencies. Dr. Logan’s responsibilities include management of toxicology resources, new test design and development, quality management, and expert testimony in forensic toxicology and chemistry.

Dr. Logan is Board Certified by the American Board of Forensic Toxicologists (ABFT), and has over eighty publications in toxicology and analytical chemistry, including papers on the effects of methamphetamine, cocaine, marijuana, alcohol, hallucinogens and depressant drugs on drivers, and postmortem redistribution of drugs. His recent work has focused on the analytical and interpretive toxicology of emerging recreational and designer drugs. In 2002, Dr. Logan was appointed Executive Director of the Robert F. Borkenstein Center for Studies of Law in Action at Indiana University, hosting the Borkenstein Alcohol and Drug Courses. Since 2010, Dr. Logan has also served as Executive Director at the Center for Forensic Science Research and Education at the Fredric Rieders Family Renaissance Foundation in suburban Philadelphia. The Center supports educational programs in the forensic sciences for high school and graduate students, and continuing professional education for forensic science professionals. Dr. Logan has made over 300 presentations to professional groups and conferences in the area of forensic science.

Dr Logan is a member of many professional organizations in forensic science, including the American Academy of Forensic Sciences (AAFS), the Society of Forensic Toxicologists, The American Association of Crime laboratory Directors, The International Council on Alcohol, Drugs and Traffic Safety, and the Canadian Society of Forensic Sciences.

In recognition of his work and contributions, Dr. Logan has received the International Association of Forensic Toxicologists mid-career achievement award in 2004, the AAFS Rolla N. Harger Award in 2010, and the National Safety Council's Robert F. Borkenstein Award in 2011.  He has served in various positions on the Board of the AAFS since 2005, and was elected President in 2013.

Charles A. McKay, MD Dr. Charles A. McKay is a medical toxicologist at Hartford Hospital and the University of Connecticut School of Medicine, where he is an associate professor of Emergency Medicine. His primary training and boards are in Internal Medicine (1986) and Emergency Medicine (1989). Dr. McKay is a diplomat of the ABMT (1991) and the ABEM Toxicology Subboard (1998). He is the Associate Medical Director of the Connecticut Poison Control Center and the director of the Toxicology Fellowship at UConn which has consultation services at three hospitals and participate in opioid surveillance and medication safety activities. As Medical Director of Occupational Health Services and Medical Review Officer for Hartford Hospital and the Connecticut Children*s Medical Center, he evaluates questions of workplace safety and toxic exposure for our 9,000 employees.
Meyers

Mr. Joel R. Meyers is currently an Assistant United States Attorney for the District of New Mexico.  He is assigned to the Organized Crime and Gangs Section where he has been since he joined the United States Attorney’s Office in August of 2008.  He is also the Office’s International Coordinator.  Prior to joining the Office he served as an Assistant District Attorney in New York City for over 10 years. He has completed dozens of felony trials from white collar fraud to homicide and organized crime.  His recent practice has focused on offenses involving narcotics and other dangerous drugs.  He has also guided the prosecution of many medical providers, including physicians, nurse practitioners, physician assistants and pharmacists.  Mr. Meyers has familiarized himself with many of the emerging issues involving synthetic controlled substances and their analogues.  Mr. Meyers is a 1997 graduate of Washington University in St. Louis where he received his J.D. and an M.A. in East Asian Studies.  He received his undergraduate degree in English (with a minor in Japanese) in 1993 at the State University of New York in Albany.

Lewis Nelson, MD

Dr. Lewis S. Nelson received his medical degree from SUNY Health Science Center in Brooklyn, NY. He completed a residency in emergency medicine at Mount Sinai School of Medicine followed by a fellowship in Medical Toxicology at New York City Poison Control Center/New York University School of Medicine. Dr. Nelson is Professor in the Department of Emergency Medicine at New York University School of Medicine and also the Director of Education for his department. He is the Director of the Fellowship in Medical Toxicology program at NYUSOM and NYCPCC. He is an attending physician in the Department of Emergency Medicine at Bellevue Hospital Center and New York University Langone Medical Center. At NYULMC, he is Chair of both the Pharmacy and Therapeutics and Medication Safety committees. Dr. Nelson has served as Chair of the Medical Toxicology Subboard, the board certifying organization for medical toxicologists. He has also been of the Food and Drug Administration's Drug Safety and Risk Management (DSaRM) Advisory Committee. In addition to editing Goldfrank's Toxicologic Emergencies, now in its 9th edition, Dr. Nelson’s educational and research interests focus on opioid toxicology, medication safety, and chemical terrorism. Dr. Nelson was first elected to the ACMT Board of Directors in 2002. He served as President from 2010 to 2012, and has had leadership roles on multiple committees.

Paul M. Wax, MD

Dr. Paul M. Wax is the Executive Director of the American College of Medical Toxicology. He received his B.A from Dartmouth College, his M.D. from the Mount Sinai School of Medicine, his Emergency Medicine training at the UCLA Hospitals, and his Medical Toxicology training at Bellevue Medicine Center / New York University. He is Board-certified in both Medical Toxicology and Emergency Medicine, and is a Fellow of the American College of Medical Toxicology. Along with his part time role as the Executive Director of ACMT, Dr. Wax is a Clinical Professor in Surgery (Emergency Medicine) at the University of Texas, Southwestern School of Medicine where he is a member of the Section of Medical Toxicology and Director of the Medical Toxicology Clinic. Before joining ACMT in 2008 as its Executive Director, and the University of Texas Southwestern in 2006 as a part-time faculty member, Dr. Wax had faculty appointments in the Departments of Emergency Medicine at the University of Rochester School of Medicine from 1991-2001 and the University of Arizona School of Medicine from 2001-2006. Dr. Wax previously served on the Board of Directors of ACMT from 1998-2008 serving as ACMT President from 2006-2008. During this tenure he chaired the ACMT Education Committee from 1998-2002. From 2002-2006 Dr. Wax served as the National Director of ACMT's Consultation Network to support the ATSDR Regional Offices and was co-founder of ACMT’s Chemical Agent of Opportunity course. From 1997-2006 Dr. Wax also served as one of the American Board of Emergency Medicine’s appointee’s on the Medical Toxicology Subboard. During this time Dr. Wax served as Editor of the Medical Toxicology Board Certification Examination as well as Chairman of the Subboard, and was also the primary author of the 2004 Core Content of Medical Toxicology. Dr. Wax has also served as a consultant to the Centers for Disease Control NCEH’s Division of Laboratory Sciences and was a member of NCEH/ATSDR Board of Scientific Counselors from 2006-2008.